MedPath

Hypofractionated radiotherapy in early laryngeal cancers

Phase 2
Recruiting
Conditions
laryngeal cancer.
Malignant neoplasm of larynx
Registration Number
IRCT20230128057262N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
49
Inclusion Criteria

Definitive diagnosis of squamous cell carcinoma of the larynx based on pathology report
Glottic lesions T1-2
No involvement of neck lymph nodes (N0)
18 to 75 years old
Performance level based on ECOG less than 3

Exclusion Criteria

Other malignant histologies of the larynx except squamous cell carcinoma
History of head and neck radiotherapy
Previous history of chemotherapy
Previous history of malignancy except skin BCC
History of diabetes or uncontrolled blood pressure
History of tracheostomy
With a history of laser microsurgery

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pathologic complete response. Timepoint: Post operation. Method of measurement: Pathologic examination.
Secondary Outcome Measures
NameTimeMethod
Side effects. Timepoint: Weekly during intervention course. Method of measurement: Radition therapy toxicity critria.
© Copyright 2025. All Rights Reserved by MedPath